On May 1, 2018 Diplomat Pharmacy, Inc. (NYSE: DPLO), reported that executives will attend the 43rd Annual Deutsche Bank Health Care Conference in Boston (Press release, Diplomat Speciality Pharmacy, MAY 1, 2018, View Source [SID1234525910]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Interim CEO Jeff Park, President Joel Saban, and Chief Financial Officer Atul Kavthekar are scheduled to present at 12:50 p.m. ET Wednesday, May 9.

A live audio-only webcast of the presentation and related materials will be available on the investor relations section of Diplomat’s website at ir.diplomat.is. The webcast and presentation materials will be online for 90 days.

On May 1, 2018 CytomX Therapeutics, Inc. (Nasdaq:CTMX), a clinical-stage biopharmaceutical company developing investigational Probody therapeutics for the treatment of cancer, reported its first quarter 2018 financial results on Wednesday, May 9, 2018, after the NASDAQ market close (Press release, CytomX Therapeutics, MAY 1, 2018, View Source;p=RssLanding&cat=news&id=2346043 [SID1234525909]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The company will not be conducting a conference call in connection with this financial results press release.

On May 1, 2018 Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes and signaling pathways of cancer cells and address unmet medical needs of patients with life-threatening hematologic cancers, reported that it will release its financial results for the quarter ended March 31, 2018, on Thursday, May 10, 2018 after the close of the market (Press release, Aptose Biosciences, MAY 1, 2018, View Source [SID1234525906]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Call & Webcast:
Thursday, May 10th @ 5:00pm Eastern Time
Toll-Free: (844) 882-7834
International: (574) 990-9707
Passcode: 2094769
Webcast: View Source

Replays available through May 17th, 2018
Toll-Free: (855) 859 2056
Replay Passcode: 2094769

The live conference call can also be accessed through a link on the Investor Relations section of Aptose’s website at ir.aptose.com. Please log onto the webcast at least 10 minutes prior to the start of the call to ensure time for any software downloads that may be required. An archived version of the webcast along with a transcript will be available on the company’s website for 30 days.

The press release, the financial statements and the management’s discussion and analysis for the quarter ended March 31, 2018 will be available on SEDAR at www.sedar.com and EDGAR at www.sec.gov/edgar.shtml

On May 1, 2018 -Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, reported that management will present company overviews at the following conferences (Press release, Alnylam, MAY 1, 2018, View Source;p=RssLanding&cat=news&id=2346040 [SID1234525905]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Deutsche Bank 43rd Annual Healthcare Conference on Tuesday, May 8, 2018 at 8:00 am ET at the InterContinental Hotel in Boston
Bank of America Merrill Lynch 2018 Healthcare Conference on Wednesday, May 16, 2018 at 5:00 pm PT (8:00 pm ET) at the Encore at Wynn Las Vegas in Las Vegas, Nevada
A live audio webcast of each presentation will be available on the Investors section of the Company’s website, www.alnylam.com. A replay will be available on the Alnylam website within 48 hours after each event.

On May 1, 2018 Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, reported that Chief Financial Officer Matthew Walsh will present at the Deutsche Bank 43rd Annual Health Care Conference in Boston, Massachusetts (Press release, Allergan, MAY 1, 2018, View Source [SID1234525904]). The presentation will begin at 10:40 a.m. Eastern Time on Tuesday, May 8, 2018.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentation will be webcast live and can be accessed on Allergan’s Investor Relations website at www.allergan.com/investors. The webcast can also be accessed through the following URL: View Source;

An archived version will be available within approximately two hours of the live presentation, and can be accessed at the same location for 90 days.